Biomedical, Clinical & Life Sciences

Apply to Internal Competition // Limit: 4 (one per program plus one additional possible for select research areas) // Tickets Available: 4
 

Limiting Language

Total submissions allowed per institution:one submission in each program category, plus one additional submission under the funding interest submission, if eligible. 

St. Baldrick’s Foundation has identified the areas below as funding interests and has donors interested in supporting meritorious projects in these areas. To encourage submissions in these priority areas, institutions may submit one additional LOI beyond the standard limited submissions. Only one additional submission is permitted per institution for the entire cycle; this does not allow one additional submission in each program or funding category. 

• Rhabdomyosarcoma 
• Brain tumors –especially atypical teratoid/rhabdoid tumor (AT/RT), diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG), and glioblastoma (GBM) 
• Burkitt lymphoma – all types, especially sporadic 
• Rhabdoid tumors - Extrarenal 

Program Descriptions

Full sponsor guidelines are linked here. 

St. Baldrick's Scholars

• The three (3) year Scholar (Career Development) Award, with an option for two (2) additional years based on progress, is meant to help develop the independent research of highly qualified individuals still early in their careers. Recipients are called St. Baldrick's Scholars. Up to $110,000/year, three-year minimum.
• Scholar (Career Development) Award LOI instructions
• Scholar (Career Development) Award Guidelines

St. Baldrick's International Scholars

• This three (3) year award, with an option for two (2) additional years based on progress, is to train researchers from low-and middle-income countries (as classified by the World Bank) to prepare them to fill specific stated needs in an area of childhood cancer research upon returning to their country of origin. Recipients are called St. Baldrick's International Scholars. Up to $110,000/year, three-year minimum.
• International Scholar LOI instructions
• International Scholar Award Guidelines

Survivorship and Supportive Care Research Grant

• These grants are for specific one-year research projects which are hypothesis-driven and focus on areas related to survivorship and supportive care of children and adolescents with cancer. Examples include but are not limited to: studies related to the burden of morbidity, cause-specific mortality, understanding the pathogenesis of treatment-related complications, patient-reported outcomes or quality of life, health communication, health promotion, and psychosocial support across the trajectory from diagnosis to survivorship or end-of-life care.
• Survivorship and Supportive Care Research Grant LOI instructions
• Survivorship and Supportive Care Research Grant Guidelines

Apply to Internal Competition // Limit: 2 // Tickets Available: 2

Limiting Language 
Submissions will be evaluated to ensure they align with our mission and funding criteria. A limit of two proposals may be submitted from the same institution, researcher, or foundation.

Program Overview
SebastianStrong Foundation is a 501c3 nonprofit organization dedicated to raising awareness of childhood cancer and accelerating the development of more targeted, less toxic treatments by funding bold, early-stage research. Since 2017, we have awarded over $4 million to cutting-edge, peer-reviewed pediatric cancer research. Through strategic partnerships, matched contributions, and follow-on funding secured by investigators, our overall impact now exceeds $6 million.
 

We exist because kids deserve better. Too many promising ideas in pediatric cancer research go unfunded due to limited institutional support, lack of commercial incentive, and minimal government investment, especially for rare and relapsed cancers. At SebastianStrong, we focus exclusively on childhood cancers, where small patient populations often mean traditional funders and pharmaceutical companies overlook research.

ABOUT THE DISCOVERY SCIENCE AWARD

The Discovery Science Award typically provides up to $500,000 in funding for groundbreaking research that aligns with our mission. In select cases, proposals demonstrating exceptional potential for impact and scalability may be considered for higher levels of support.

Our Scientific Advisory Board, composed of leading pediatric oncologists and researchers, conducts a two-stage review process. First, Letters of Intent (LOIs) are evaluated to identify projects that best align with our mission and funding priorities. Selected applicants are then invited to submit a full proposal, which is reviewed in detail to determine final award decisions. Funding recommendations are made by the Scientific Advisory Board and approved by the Foundation’s Board of Directors.

To be considered for funding, proposals must meet the following criteria:

1. Are focused on pediatric cancer
2. Will lead to less toxic, more targeted treatments
3. Are clearly communicated in lay terms (accessible to our Board and donor community)
4. Demonstrate strong potential to progress toward a clinical trial in 1-3 years

We welcome new, ongoing, and updated peer-reviewed research. However, we do not accept in-progress or ongoing clinical trials. Any author or researcher conflict of interest must be disclosed at the time of submission. All submissions are treated as CONFIDENTIAL and are accessible only to members of SebastianStrong’s Board of Directors and Scientific Advisory Board until the time of award. We are happy to execute NDAs upon request.

WHAT WE’RE LOOKING FOR

SebastianStrong funds one or more proposals each year that advance meaningful change in pediatric cancer treatment. We are especially interested in research that:

• Focuses on pediatric cancers with low survival rates or high relapse rates
• Has transitional potential within 36 months
• Pursues underfunded or unconventional approaches that could change the status quo

Limit: Each research center may appear on one LOI/Proposal

G. Coronado (Health Equity Research Center)

Limiting Language
Centers may be included in only one application. Duplicate applications will be marked as ineligible.

Purpose
Through this CFP, RWJF will expand its efforts to transform deeply rooted beliefs about which data and research methods are valued, whose perspectives are prioritized, and which populations deserve resources. This CFP works to achieve transformation by incorporating a holistic funding approach that focuses on the infrastructure and capacity support that research centers need to meaningfully engage in research in the first place. RWJF understands that no single philanthropy can completely fill the gap left by ongoing federal funding cuts; however, this CFP demonstrates strong support for research, researchers, and research centers that are well positioned to pave the way toward a future where health is not a privilege, but a right.  

RWJF believes in health equity research that is grounded in systems thinking; supports and disseminates evidence identifying and implementing structural solutions to racial and health inequities; and increases power, representation, and agency among historically underrepresented researchers. By supporting the infrastructure and capacity-building needs of MSIs, this opportunity strengthens their ability to generate critical evidence and to cultivate transformative, actionable solutions toward health equity.  

This CFP seeks mission-aligned institutions interested in participating in cohort-style peer learning to advance their ability to engage in health equity research and apply for competitive funding opportunities in the future.  

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding.

Executive Summary
The Bureau of Emerging Threats (ET) leads the Department of State in anticipating and responding to national security challenges arising from adversary use of new technologies across cyberspace, outer space, critical infrastructure and undersea domains, quantum technologies, and artificial intelligence (AI). ET focuses on protecting U.S. national security in these areas of strategic and technological competition using diplomatic tools and interagency capabilities as part of coordinated foreign policy responses.

Within ET, the Office of Critical Infrastructure Security (ET/CI) is responsible for addressing novel threats and disruptions to critical infrastructure that threaten lives, economic stability, and national power. ET/CI addresses threat vectors targeting major critical infrastructure sectors, including energy systems, communications networks, transportation and logistics, financial systems, healthcare, and water, and works to coordinate “upgrade and secure” efforts with allies and partners, counter attacks against data centers, and protect against cloud security vulnerabilities.

In the Western Hemisphere, adversaries have exploited weak cyber defenses in government networks and critical infrastructure to gain intelligence advantages, potential coercive leverage over sovereign decision-making, and latent access pathways that may extend to U.S. interests. Argentina, under the Milei administration, has signaled that it seeks close alignment with the United States on strategic and economic issues, including a deliberate transition away from untrusted foreign digital infrastructure suppliers in favor of trusted, market-oriented partners.

Persistent and sophisticated cyber threats—including advanced persistent threats (APTs), targeted ransomware, and espionage campaigns—continue to target Argentine ministries and critical infrastructure. Without a mature national-level Security Operations Center (SOC) with clear authorities, mission, charter, and well-trained staff, a country’s ability to detect, analyze, and respond to such threats in a coordinated manner remains limited.

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Duplicate or Multiple Submissions – Only one application will be accepted from each organization or institution. NIFA will accept the most recent application if an applicant submits duplicate or multiple submissions.

Executive Summary
NIFA requests applications for the OAVFR program for FY 2026 to encourage and assist farmers and ranchers with owning and operating farms and ranches and accessing the full range of agricultural, forestry, and related programs offered by USDA. The amount for awards in FY 2026 is approximately $23,800,000. This notice identifies the objectives for OAVFR program projects, deadlines, funding information, eligibility criteria for projects and applicants, and application forms and associated instructions.

Limit: 1 // Tickets Available: 0

J. Parlin (Cooperative Extension)

Limiting Language
Only one proposal per organization will be accepted in the grants cycle.

Overview
The Delta Dental of Arizona Foundation (DDAZF) Grant Program supports projects and services promoting good oral health/vision practices, increasing access to dental/vision care, nutrition programs, food banks and pantries.

It is the intention that this funding will:

• Encourage and advance the integration of oral health and overall health.
• Increase access to oral health or vision services to underserved communities.
• Promote collaboration across a wide range of health providers in Arizona.
• Increase use of proven approaches into greater and more widespread practice.
• Increase food security.
• Improve nutritional quality of available food.
• Increase nutrition awareness.

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language 
Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed

Purpose
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BBB) and testing them clinically. Successful early-stage trials of new drugs from this NOFO would transition seamlessly to later stage trials using well-established NCI clinical trial mechanisms.

To implement this concept, a highly collaborative GBM Therapeutics Network (GTN) of cross-cutting teams will be established, each team capable of driving therapeutic agent(s) from pre-clinical development, through investigational new drugs (IND) studies, into pilot clinical studies in humans. Appropriate therapeutic agents include: (1) novel agents or (2) agents or combinations approved for other indications and repurposed for treatment of GBM following appropriate preclinical studies. The scope of the NOFO, from late pre-clinical through early (Phase 0/1) clinical studies, uniquely spans a gap in the GBM drug development process.

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Applicant organizations may submit only one application.

Purpose
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications for Centers within the NIDDK Cooperative Centers of Experimental in Hematology (CCEH) Program. Each Center will support one to three Biomedical Research Cores and an Administrative Core, including an Enrichment Program. Each Center is expected to work collaboratively with NIDDK, the Hematology Coordinating Center (HCC), and the other CCEH Centers. The CCEH Program is designed to increase access to critical research resources and expertise unique to nonmalignant hematology research. By providing innovative technology, resources, and expertise to the greater hematology research community, the program will serve as a national hub, aimed at recruiting and retaining both junior scientists just beginning their careers in the field as well as established investigators from other domains.

Limit: 1 // Tickets Available: 0 

S. Dahmer (Andrew Weil Center for Integrative Medicine)

Limiting Language
Only one entry per institution is permitted, either as an individual entry or as a partnership entry with other institution(s). Two or more institutions that have formed close collaborations to enhance nutrition education across the institutions may submit to this Challenge as a partnership.

Overview
The National Institutes of Health (NIH) Office of Nutrition Research (ONR) announces the “Integration of Nutrition Training into Health Care Education” Challenge. ONR’s mission is to stimulate innovative research to address the complexities of nutrition, its ecology, and its critical role in health across the lifespan for all. The goal of this challenge is to identify, evaluate, and promote effective, scalable, and evidence-based approaches to integrating nutrition training into medical and nursing education, including both established programs and emerging models with strong potential for dissemination. The total prize purse from NIH for this Challenge is up to $2,100,000.

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
An individual applicant may not submit more than one application in response to this NOFO and may not be offered more than one award.

Executive Summary
The U.S. Department of Agriculture, Foreign Agricultural Service announces this notice of funding opportunity (NOFO) to support the Assisting Specialty Crop Exports (ASCE) Initiative by issuing a new award. The award is contingent on the availability of funding. This initiative aims to enhance U.S. specialty crop market access in key export markets and support producers with cost-effective approaches for post-harvest pest control and maintaining quality during storage and export. This opportunity is available to U.S. academic institutions, nonprofits with or without 501(c)(3) designation, U.S. trade associations, U.S. agricultural cooperatives, international organizations based in the United States, and any other United State-based entity including private sector businesses. The award is intended to assist U.S. tree nut and durable specialty crop producers and agribusinesses by developing the processes and technologies for phytosanitary validation and traceability of low-oxygen storage and packaging systems. Applicants must be registered in SAM.gov and apply through USDA’s ezFedGrants online system, both of which require an identity-proofed login.gov account. 

Benefits to the United States: 

• This program makes America more prosperous by strengthening trade. 
• This program makes America more prosperous by expanding and developing new markets in current and potential trading partners.